Reents Scott T
SEC CIK 1937048 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | EVP, CFO | 38.8K | — | $8.70M | 12 | 2023-02-16 | 2026-02-27 |
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABBV | AbbVie | Reents Scott T | EVP, CFO | F - Tax | $232.08 | -21.6K | 38.8K | -36% | -$5.02M | |
| DM | 2026-02-20 | 2026-02-18 | ABBV | AbbVie | Reents Scott T | EVP, CFO | A - Grant | $0.00 | +48.8K | 45.5K | New | $0 |
| 2025-03-18 | 2025-03-14 | ABBV | AbbVie | Reents Scott T | EVP, CFO | S - Sale | $212.34 | -17.6K | 11.6K | -60% | -$3.75M | |
| 2025-03-04 | 2025-02-28 | ABBV | AbbVie | Reents Scott T | EVP, CFO | F - Tax | $205.02 | -11.0K | 29.2K | -27% | -$2.25M | |
| DM | 2025-02-18 | 2025-02-13 | ABBV | AbbVie | Reents Scott T | EVP, CFO | A - Grant | $0.00 | +24.8K | 32.6K | +317% | $0 |
| D | 2024-03-01 | 2024-02-23 | ABBV | AbbVie | Reents Scott T | EVP, CFO | S - Sale+OE | $177.44 | -14.1K | 27.1K | -34% | -$2.51M |
| D | 2024-03-01 | 2024-02-28 | ABBV | AbbVie | Reents Scott T | EVP, CFO | F - Tax | $178.99 | -11.6K | 15.4K | -43% | -$2.08M |
| D | 2024-03-01 | 2024-02-23 | ABBV | AbbVie | Reents Scott T | EVP, CFO | M - OptEx | $61.36 | +14.1K | 41.2K | +52% | +$867.6K |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | Reents Scott T | EVP, CFO | A - Grant | $0.00 | +26.3K | 27.1K | +3,245% | $0 |
| M | 2023-03-02 | 2023-03-01 | ABBV | AbbVie | Reents Scott T | EVP, CFO | S - Sale | $153.08 | -15.9K | 1,659 | -91% | -$2.44M |
| 2023-03-02 | 2023-02-28 | ABBV | AbbVie | Reents Scott T | EVP, CFO | F - Tax | $154.28 | -12.7K | 16.8K | -43% | -$1.96M | |
| DM | 2023-02-21 | 2023-02-16 | ABBV | AbbVie | Reents Scott T | EVP, CFO | A - Grant | $0.00 | +28.6K | 27.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations